BCM
VNRX icon

BlueCrest Capital Management’s VolitionRx Ltd VNRX Stock Holding History

BlueCrest Capital Management’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,239
Closed -$81K – 1044
2019
Q1 		$81K Buy
+1,239
New +$69.2K ﹤0.01% 1102
2018
Q3 		– Sell
-551
Closed -$22K – 1819
2018
Q2 		$22K Hold
551
– – ﹤0.01% 1446
2018
Q1 		$26K Buy
+551
New +$32.2K ﹤0.01% 1443

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlueCrest Capital Management's VNRX Position: Q2 2019 in Review

BlueCrest Capital Management sold out of VolitionRx Ltd (VNRX) in Q2 2019, closing a stake of 1,239 shares — an estimated $81K sold.

BlueCrest Capital Management first reported a position in VNRX in Q1 2018 and held it in 3 quarters. The position peaked at $81K in Q1 2019. 25 funds tracked by Wall St. Rank hold VNRX as of Q2 2019.

  • BlueCrest Capital Management reported no remaining VolitionRx Ltd position as of Q2 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 1,239 VolitionRx Ltd shares in Q2 2019, an estimated $81K.
  • BlueCrest Capital Management first reported a position in VolitionRx Ltd in Q1 2018 and held it in 3 quarters.
  • BlueCrest Capital Management's VolitionRx Ltd position peaked at $81K in Q1 2019.
  • 25 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.